nach oben

Supportive Care in Cancer

Erschienen in:

01.08.2007 | Original Article

Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM)

verfasst von: Lynda G. Balneaves, Tracy L. O. Truant, Mary Kelly, Marja J. Verhoef, B. Joyce Davison

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Abstract

Goals of work

The purpose of this study was to explore the personal and social processes women with breast cancer engaged in when making decisions about complementary and alternative medicine (CAM). The overall aim was to develop a conceptual model of the treatment decision-making process specific to breast cancer care and CAM that will inform future information and decision support strategies.

Materials and methods

Grounded theory methodology explored the decisions of women with breast cancer using CAM. Semistructured interviews were conducted with 20 women diagnosed with early-stage breast cancer. Following open, axial, and selective coding, the constant comparative method was used to identify key themes in the data and develop a conceptual model of the CAM decision-making process.

Main results

The final decision-making model, Bridging the Gap, was comprised of four core concepts including maximizing choices/minimizing risks, experiencing conflict, gathering and filtering information, and bridging the gap. Women with breast cancer used one of three decision-making styles to address the paradigmatic, informational, and role conflict they experienced as a result of the gap they perceived between conventional care and CAM: (1) taking it one step at a time, (2) playing it safe, and (3) bringing it all together.

Conclusions

Women with breast cancer face conflict and anxiety when making decisions about CAM within a conventional cancer care context. Information and decision support strategies are needed to ensure women are making safe, informed treatment decisions about CAM. The model, Bridging the Gap, provides a conceptual framework for future decision support interventions.

Ashikaga T, Bosompra K, O’Brien PJ, Nelson L (2002) Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 10:542–548PubMedCrossRef

Balneaves LG, Bottorff JL, Hislop TG, Herbert C (2006) Levels of commitment: exploring complementary therapy use by women with breast cancer. J Altern Complement Med 12:459–466PubMedCrossRef

Balneaves LG, Kristjanson LJ, Tataryn D (1999) Beyond convention: describing complementary therapy use by women living with breast cancer. Patient Educ Couns 38:143–153PubMedCrossRef

Balneaves LG, Long B (1999) An embedded decisional model of stress and coping: implications for exploring treatment decision making by women with breast cancer. J Adv Nurs 30:882–892PubMedCrossRef

Barrett B, Marchand L, Scheder J et al (2003) Themes of holism, empowerment, access, and legitimacy define complementary, alternative, and integrative medicine in relation to conventional biomedicine. J Altern Complement Med 9:937–947PubMedCrossRef

Bekker HL, Hewison J, Thornton JG (2003) Understanding why decision aids work: linking process with outcome. Patient Educ Couns 50:323–329PubMedCrossRef

Ben-Arye E, Frenkel M, Margalit RS (2004) Approaching complementary and alternative medicine use in patients with cancer: questions and challenges. J Ambul Care Manage 27:53–62PubMed

Blumer H (1969) Symbolic interactionism: perspective and method. University of California Press, Berkeley, CA

Boon H, Brown JB, Gavin A, Kennard MA, Stewart M (1999) Breast cancer survivors’ perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. Qual Health Res 9:639–653PubMedCrossRef

10.

Boon H, Brown JB, Gavin A, Wardell D (2000) What are the experiences of women with breast cancer as they decide whether to use complementary/alternative medicine. West J Med 173:39PubMedCrossRef

11.

Boon H, Stewart M, Kennard MA et al (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18:2515–2521PubMed

12.

Butow P, Tattersall M (2005) Shared decision making in cancer care. Clin Psychol 9:54–58CrossRef

13.

Capsi O, Koithan M, Criddle MW (2004) Alternative medicine or “alternative” patients: a qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine. Med Decis Mak 24:64–79CrossRef

14.

Charles C, Whelan T, Gafni A, Reyno L, Redko C (1998) Doing nothing is no choice: lay constructions of treatment decision-making among women with early-stage breast cancer. Sociol Health Illn 20:71–95CrossRef

15.

Chatwin J, Tovey P (2004) Complementary and alternative medicine (CAM), cancer and group-based action: a critical review of the literature. Eur J Cancer Care 13:210–218CrossRef

16.

Davison BJ, Gleave ME, Goldenberg SL, Degner LF, Hoffart D, Berkowitz J (2002) Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nurs 25:42–49PubMedCrossRef

17.

de Lemos ML, John L, Nakashima L, O’Brien RK, Taylor S (2004) Advising cancer patients on natural health products—a structured approach. Ann Pharmacother 38:1406–1411PubMedCrossRef

18.

Eisenberg DM (1997) Advising patients who seek alternative medical therapies. Ann Intern Med 127:61–69PubMed

19.

Ernst E, Cohen MH, Stone J (2004) Ethical problems arising in evidence based complementary and alternative medicine. J Med Ethics 30:156–159PubMedCrossRef

20.

Fischer M, Visser A, Voerman B, Garssen B, van Andel G, Bensing J (2006) Treatment decision making in prostate cancer: patients’ participation in complex decisions. Patient Educ Couns 63:308–313PubMedCrossRef

21.

Gerber B, Scholz C, Reimer T, Briese V, Janni W (2006) Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat 95:199–209PubMedCrossRef

22.

Glaser BG, Strauss AL (1967) The discovery of grounded theory: strategies for qualitative research. Aldin, Chicago

23.

Gwede CK, Pow-Sang J, Seigne J et al (2005) Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer 104:1381–1390PubMedCrossRef

24.

Hann D, Baker F, Denniston MM, Entrekin N (2005) Long-term breast cancer survivors’ use of complementary therapies: perceived impact on recovery and prevention of recurrence. Integr Cancer Ther 4:14–20PubMedCrossRef

25.

Hann DM, Baker F, Denniston MM (2003) Oncology professionals’ communication with cancer patients about complementary therapy: a survey. Complement Ther Med 11:184–190PubMedCrossRef

26.

Janis IL, Mann L (1977) Decision making: a psychological analysis of conflict, choice, and commitment. Free, New York

27.

Lazarus RS, Folkman S (1984) Stress, appraisal, and coping. Springer, New York

28.

Lesperance ML, Olivotto IA, Forde N et al (2002) Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat 76:137–143PubMedCrossRef

29.

O’Connor AM, Jacobsen MJ, Stacey D (2002) An evidence-based approach to managing women’s decisional conflict. JOGN Nurs 31:570–581

30.

Marcus DM, Grollman AP (2002) Botanical medicines—the need for new regulations. N Engl J Med 347:2073–2076PubMedCrossRef

31.

Montbriand MJ (1995) Decision tree model describing alternate health care choices made by oncology patients. Cancer Nurs 18:104–117PubMedCrossRef

32.

O’Connor AM, Fiset V, DeGrasse C et al (1999) Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monographs 25:67–80PubMed

33.

O’Connor AM, Stacey D, Rovner D et al (2001) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2:CD001431

34.

Panel on Definition and Description, of the 1995 Office of Alternative Medicine CAM Research Methodology Conference (1997) Defining and describing complementary and alternative medicine. Altern Ther Health Med 3:49–57

35.

Pierce PF (1993) Deciding on breast cancer treatment: a description of decision behavior. Nurs Res 42:22–28PubMedCrossRef

36.

Reaby LL (1998) The quality and coping patterns of women’s decision-making regarding breast cancer surgery. Psychooncology 7:252–262PubMedCrossRef

37.

Rees RW, Feigel I, Vickers A, Zollman C, McGurk R, Smith C (2000) Prevalence of complementary therapy use by women with breast cancer. A population-based survey. Eur J Cancer 36:1359–1364PubMedCrossRef

38.

Richardson MA, Mâsse LC, Nanny K, Sanders C (2004) Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer 12:797–804PubMedCrossRef

39.

Roberts CS, Baker F, Hann D et al (2005) Patient-physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol 23:35–60PubMedCrossRef

40.

Salmenpera L, Suominen T, Vertio H (2003) Physicians’ attitudes towards the use of complementary therapies (CTs) by cancer patients in Finland. Eur J Cancer Care 12:358–364CrossRef

41.

Slovic P, Fischhoff B, Lichtenstein S (1977) Behavioral decision theory. Annu Rev Psychol 28:1–39CrossRef

42.

Staples JK, Wilson AT, Pierce B, Gordon JS (2007) Effectiveness of CancerGuides a study of an integrative cancer care training program for health professionals. Integr Cancer Ther 6:14–24PubMedCrossRef

43.

Strauss AL, Corbin JM (1998) Basics of qualitative research: techniques and procedures for developing grounded theory. Sage, Thousand Oaks

44.

Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H (2002) Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psychooncology 11:212–220PubMedCrossRef

45.

Thorne S, Paterson B, Russell C, Schultz A (2002) Complementary/alternative medicine in chronic illness as informed self-care decision making. Int J Nurs Stud 39:671–683PubMedCrossRef

46.

Truant T, Bottorff JL (1999) Decision making related to complementary therapies: a process of regaining control. Patient Educ Couns 38:131–142PubMedCrossRef

47.

Verhoef MJ, White MA (2002) Factors in making the decision to forgo conventional cancer treatment. Cancer Pract 10:201–207PubMedCrossRef

48.

Wallberg BM, H, Nuystedt M, Bolund C, Degner LF, Wilking N (2000) Information needs and preferences for participation in treatment decisions among Swedish breast cancer patients. Acta Oncol 39:467–476PubMedCrossRef

Titel: Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM)
verfasst von: Lynda G. Balneaves
Tracy L. O. Truant
Mary Kelly
Marja J. Verhoef
B. Joyce Davison
Publikationsdatum: 01.08.2007
Verlag: Springer-Verlag
Erschienen in: Supportive Care in Cancer / Ausgabe 8/2007
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-007-0282-3

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM)

Abstract

Goals of work

Materials and methods

Main results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Goals of work

Materials and methods

Main results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2007

Supportive Care and CAM—an integrative, but cautious encounter

A non-randomized comparison of mindfulness-based stress reduction and healing arts programs for facilitating post-traumatic growth and spirituality in cancer outpatients

Twenty years of therapeutic touch in a Canadian cancer agency: lessons learned from a case study of integrative oncology practice

What is the state of the evidence on the mind–cancer survival question, and where do we go from here? A point of view

Cancer and complementary medicine: an international perspective

Presenting the alternative: cancer and complementary and alternative medicine in the Canadian print media

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie